Profile data is unavailable for this security.
About the company
Shanghai Rendu Biotechnology Co Ltd is a China-based company mainly engaged in the research, development and sales of molecular diagnostic reagents. The Company utilizes ribonucleic acid (RNA) isothermal amplification technology to provides multiple series of diagnostic reagents, including respiration series, reproduction series, enterovirus series, blood-borne diseases series and other diagnostic reagents. The Company also designs and manufactures medical instruments. The Company mainly sells its products within domestic market.
- Revenue in CNY (TTM)180.85m
- Net income in CNY-8.77m
- Incorporated2007
- Employees528.00
- LocationShanghai Rendu Biotechnology Co LtdF3 Block 7 #590 Ruiqing RdEast Zone, Zhangjiang High- Tech ParkShanghai 201201ChinaCHN
- Phone+86 2 150720069
- Fax+86 2 150720069
- Websitehttp://www.rdbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hangzhou Tianmushan Phrmtcl ntrprs C Ltd | 137.86m | -38.94m | 993.72m | 380.00 | -- | 36.25 | -- | 7.21 | -0.3198 | -0.3198 | 1.13 | 0.2251 | 0.4619 | 2.30 | 3.90 | 362,781.80 | -13.21 | -6.93 | -54.44 | -18.92 | 21.16 | 33.95 | -28.59 | -16.42 | 0.5282 | -4.37 | 0.6609 | -- | 11.82 | -19.42 | 43.35 | -- | -24.89 | -- |
| Dali Pharmaceutical Co Ltd | 65.70m | -22.85m | 1.14bn | 272.00 | -- | 3.04 | -- | 17.39 | -0.104 | -0.104 | 0.2991 | 1.71 | 0.1381 | 1.15 | 15.89 | 241,555.10 | -4.80 | -2.31 | -5.61 | -2.77 | 22.16 | 65.39 | -34.78 | -7.00 | 3.11 | -- | 0.0593 | -- | -34.06 | -26.30 | -13.16 | -- | 16.34 | -- |
| AVE Science & Technology Co Ltd | 206.22m | 24.46m | 1.15bn | 492.00 | 46.84 | 2.32 | -- | 5.56 | 0.3597 | 0.3597 | 3.03 | 7.28 | 0.3795 | 2.04 | 33.65 | 419,148.40 | 4.50 | 7.21 | 4.92 | 8.18 | 55.69 | 58.93 | 11.86 | 15.48 | 5.60 | -- | 0.00 | 22.46 | 1.79 | 5.88 | 19.81 | -4.62 | -23.68 | -- |
| Shanghai Rendu Biotechnology Co Ltd | 180.85m | -8.77m | 1.33bn | 528.00 | -- | 1.40 | -- | 7.34 | -0.2192 | -0.2192 | 4.52 | 23.78 | 0.1695 | 1.82 | 1.99 | 342,521.40 | -0.8215 | -- | -0.8869 | -- | 70.19 | -- | -4.85 | -- | 13.78 | -- | 0.008 | -- | 3.95 | -- | -63.89 | -- | -- | -- |
| Shanghai Rightongene Biotechnlgy Co Ltd | 265.52m | 7.17m | 1.40bn | 501.00 | 188.84 | 1.51 | -- | 5.29 | 0.1332 | 0.1332 | 4.75 | 16.67 | 0.2540 | 1.09 | 1.40 | 529,970.30 | -0.0901 | 4.16 | -0.098 | 4.49 | 75.02 | 70.45 | -0.3548 | 11.62 | 10.43 | -- | 0.0284 | 5.90 | -39.14 | 2.84 | -80.41 | -11.46 | 19.65 | -- |
| Shaanxi Kanghui Pharmaceutical Co Ltd | 588.60m | -70.10m | 1.45bn | 828.00 | -- | 1.48 | -- | 2.47 | -0.7018 | -0.7018 | 5.89 | 9.84 | 0.289 | 2.23 | 3.02 | 710,868.00 | -4.51 | 1.41 | -6.35 | 1.71 | 30.41 | 45.74 | -15.60 | 4.48 | 0.8839 | -2.79 | 0.4034 | 32.34 | 11.01 | 6.01 | -272.84 | -- | 107.49 | -- |
| Shanghai Serum Bio-Technology Co Ltd | 192.49m | 37.23m | 1.59bn | 321.00 | 42.58 | 1.46 | -- | 8.24 | 0.3441 | 0.3441 | 1.78 | 10.05 | 0.1689 | 0.9282 | 6.82 | 599,656.40 | 3.27 | 10.43 | 3.32 | 10.84 | 75.08 | 80.54 | 19.34 | 32.57 | 50.03 | -- | 0.0119 | 64.93 | 9.14 | 5.67 | -39.54 | -1.62 | 13.07 | -- |
| Shanghai Jiaoda Onlly Co Ltd | 280.54m | -39.86m | 1.64bn | 935.00 | -- | 5.61 | -- | 5.83 | -0.0514 | -0.0514 | 0.362 | 0.3761 | 0.3475 | 5.15 | 4.63 | 300,042.20 | -4.64 | -7.62 | -7.62 | -10.70 | 18.03 | 40.06 | -13.36 | -27.01 | 0.6301 | -1.40 | 0.3455 | -- | -21.43 | 2.65 | 92.96 | -- | -34.81 | -- |
| Guangzhou LBP Medicine Scnc&Tech Co Ltd | 508.01m | 40.23m | 1.71bn | 907.00 | 42.50 | 1.34 | -- | 3.36 | 0.4292 | 0.4292 | 5.32 | 13.61 | 0.3719 | 2.12 | 2.15 | 560,104.20 | 1.83 | 5.10 | 1.91 | 5.55 | 67.83 | 75.15 | 4.91 | 12.97 | 6.70 | -- | 0.0068 | 24.42 | -1.99 | 10.18 | -6.18 | -8.21 | -2.98 | -- |
Data as of Mar 13 2024. Currency figures normalised to Shanghai Rendu Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
9.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2023 | 272.70k | 3.33% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 267.14k | 3.27% |
| Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2023 | 138.87k | 1.70% |
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 30.59k | 0.37% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 17.99k | 0.22% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2023 | 4.36k | 0.05% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2023 | 1.64k | 0.02% |
| Morgan Stanley Huaxin Fund Management Co., Ltd.as of 30 Jun 2023 | 1.64k | 0.02% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2023 | 1.64k | 0.02% |
| Fortune & Royal Asset Management Co., Ltd.as of 30 Jun 2023 | 1.64k | 0.02% |
More ▼
Data from 30 Jun 2023 - 02 May 2024Source: FactSet Research Systems Inc.
